Sandra Demaria: Who Is Shaping the Future of Cancer Immunotherapy at SITC 2026?
Sandra Demaria/radiationoncology.weillcornell.org

Sandra Demaria: Who Is Shaping the Future of Cancer Immunotherapy at SITC 2026?

Sandra Demaria, Professor at Weill Cornell Medicine, shared on LinkedIn:

“Fantastic science SITC 2026, a global gathering of scientists and physicians at all career stages presenting innovative agents, targets, and approaches to eliminate cancer by leveraging the power of the immune system!

Proud of Maud Charpentier and Maria Cecilia Lira of Weill Cornell Medicine for being awarded a Young Investigator Abstract Travel Award!”

Sandra Demaria: Who Is Shaping the Future of Cancer Immunotherapy at SITC 2026?

You can also read: Parker Institute to Showcase Advances in Cancer Vaccines, Cell Therapies, and Next-Generation Immunotherapies at SITC 2026

Sandra Demaria: Who Is Shaping the Future of Cancer Immunotherapy at SITC 2026?